Similar articles for PMID: 27844413

Year	Number of Results
1982	1
1983	1
1985	1
1986	1
1988	1
1990	2
1992	2
1994	1
1995	1
1996	1
1998	3
1999	3
2001	4
2002	2
2003	2
2004	2
2005	1
2006	3
2007	5
2008	6
2009	2
2010	8
2011	13
2012	23
2013	19
2014	20
2015	12
2016	24
2017	33
2018	31
2019	11
2020	23
2021	32
2022	29
2023	12
2024	0

1

Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications.

Morbelli S, Ferrarazzo G, Pomposelli E, Pupo F, Pesce G, Calamia I, Fiz F, Clapasson A, Bauckneht M, Minuto M, Sambuceti G, Giusti M, Bagnasco M. Morbelli S, et al. J Endocrinol Invest. 2017 Apr;40(4):417-424. doi: 10.1007/s40618-016-0578-6. Epub 2016 Nov 14. J Endocrinol Invest. 2017. PMID: 27844413

2

Correlation of 18F-FDG PET/CT findings with histopathological results in differentiated thyroid cancer patients who have increased thyroglobulin or antithyroglobulin antibody levels and negative 131I whole-body scan results.

Ozkan E, Aras G, Kucuk NO. Ozkan E, et al. Clin Nucl Med. 2013 May;38(5):326-31. doi: 10.1097/RLU.0b013e318286827b. Clin Nucl Med. 2013. PMID: 23486319

3

Utility of 8F-FDG PET/CT in well differentiated thyroid carcinoma with high serum antithyroglobulin antibody.

Kingpetch K, Pipatrattana R, Tepmongkol S, Sirisalipoch S, Chaiwatanarat T. Kingpetch K, et al. J Med Assoc Thai. 2011 Oct;94(10):1238-44. J Med Assoc Thai. 2011. PMID: 22145510

4

Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.

Salvatore B, Paone G, Klain M, Storto G, Nicolai E, D'Amico D, Della Morte AM, Pace L, Salvatore M. Salvatore B, et al. Q J Nucl Med Mol Imaging. 2008 Mar;52(1):2-8. Q J Nucl Med Mol Imaging. 2008. PMID: 17538522 Free article.

5

Prognostic significance of FDG PET/CT on the follow-up of patients of differentiated thyroid carcinoma with negative 131I whole-body scan and elevated thyroglobulin levels: correlation with clinical and histopathologic characteristics and long-term follow-up data.

Vural GU, Akkas BE, Ercakmak N, Basu S, Alavi A. Vural GU, et al. Clin Nucl Med. 2012 Oct;37(10):953-9. doi: 10.1097/RLU.0b013e31825b2057. Clin Nucl Med. 2012. PMID: 22899202 Clinical Trial.

6

Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters.

Araz M, Soydal Ç, Özkan E, Akkuş P, Nak D, Küçük NÖ, Kır KM. Araz M, et al. Cancer Biother Radiopharm. 2021 Jun;36(5):425-432. doi: 10.1089/cbr.2019.3203. Epub 2020 May 5. Cancer Biother Radiopharm. 2021. PMID: 32379488

7

The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody.

Liu Y. Liu Y. Nucl Med Commun. 2016 Jun;37(6):577-82. doi: 10.1097/MNM.0000000000000480. Nucl Med Commun. 2016. PMID: 26813991 Review.

8

Risk factors and stratification for recurrence of patients with differentiated thyroid cancer, elevated thyroglobulin and negative I-131 whole-body scan, by restaging ¹⁸F-FDG PET/CT.

Okuyucu K, Ince S, Alagoz E, Emer O, San H, Balkan E, Ayan A, Meric C, Haymana C, Acıkel C, Gunalp B, Karacalioglu AO, Arslan N. Okuyucu K, et al. Hell J Nucl Med. 2016 Sep-Dec;19(3):208-217. doi: 10.1967/s002449910402. Epub 2016 Nov 8. Hell J Nucl Med. 2016. PMID: 27824959

9

¹⁸F-FDG PET/CT and ultrasonogrpahy in differentiated thyroid carcinoma patients with elevated serum levels of antithyroglobulin antibody, negative Tg and whole body ¹³¹I scan.

Liu J, Liu B, Yu Y, Chao F, Liu Y, Han X. Liu J, et al. Hell J Nucl Med. 2018 Jan-Apr;21(1):24-27. doi: 10.1967/s002449910703. Epub 2018 Mar 20. Hell J Nucl Med. 2018. PMID: 29550843 Free article.

10

[Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].

Zöphel K, Wunderlich G, Liepach U, Koch R, Bredow J, Franke WG. Zöphel K, et al. Nuklearmedizin. 2001 Oct;40(5):155-63. Nuklearmedizin. 2001. PMID: 11727628 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

297 results

Results by year